Cephalon: Analysts' Upgrades, Downgrades

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Cephalon (CEPH) downgraded at BofA/Merrill to Neutral from Buy on valuation. Maintain $75 price target. 2010 and 2011 EPS estimates held at $6.52 and $6.70, respectively.

Cephalon (CEPH) target raised at UBS to $80. Company is seeing better prescription trends. Buy rating.

DuPont Fabros Technology (DFT) initiated at Barclays with an Overweight rating and $25 price target. 2010 and 2011 EPS estimates set at $1.24 and $1.60, respectively.

Digital River (DRIV) upgraded at FBR from Market Perform to Outperform. Company is likely seeing an improved business pipeline. $36 price target.

Fresh Del Monte (FDP) downgraded at Suntrust from Buy to Neutral. See few meaningful catalysts on the horizon.

Public Service Enterprise (PEG) rated new Neutral at Goldman. $34 price target. Earnings growth in the regulated business will likely be offset by lower merchant generation results.

Psychiatric Solutions (PSYS) downgraded at Piper Jaffray. Rating lowered to Underweight from Neutral. Price target raised to $30 from $24. Maintains 2010 EPS estimates of $2.30.

SAIC(SAI) downgraded at Wells to Market Perform. Company lowered guidance as it's seeing award delays.

Wellpoint(WLP) upgraded at BMO from Market Perform to Outperform. $75 price target.

STOCK COMMENTS / EPS CHANGES

Applied Materials (AMAT) estimates higher at Credit Suisse after positive analyst day. 2010 and 2011 EPS estimates improved to $0.75 and $1.00, respectively. Maintain Neutral rating and $15.50 target.

Applied Materials (AMAT) numbers boosted at UBS. Estimates were increased through 2011. Company is seeing higher demand across the board. Buy rating and new $18 price target.

Cliffs Natural (CLF) estimates raised at Morgan Stanley. CLF estimates were increased through 2011. Company will benefit from higher iron ore prices. Equal-weight rating.

Freeport-McMoran (FCX) estimates raised at Morgan Stanley through 2011. Company is positioned to benefit from higher copper prices. Equal-weight rating.

Garmin (GRMN) target, estimates boosted at Barclays. GRMN price target increased by dollar to $34 on strong PND growth. 2010 EPS estimate raised to $2.97, 2011 held at $2.75. Maintain Equal Weight rating.

Goldman Sachs (GS) numbers lowered at KBW. Shares of GS now seen reaching $195. Estimates also reduced, as the company likely saw lower investment banking revenue this quarter.